One CRISPR Infusion Cuts Dangerous Cholesterol for a Year in Early Human Trial
An experimental gene-editing therapy has produced substantial and lasting reductions in dangerous blood fats after only a single treatment, offering early evidence that CRISPR technology could eventually transform how some severe cholesterol…
